AnalystsAlex SchwartzAlex Schwartz's Stock Forecasts
AnalystsAlex Schwartz
Sectors:
Industries:
Analyst Ranking
Bottom 12%
#4031 out of 4559 analysts
Average Return
-42.18%
Win Rate
0%0 out of 7
Risk vs Reward
Poor
Good
Alex Schwartz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
No Ratings AvailableAlex Schwartz doesn't have any winning ratings in our database | |||||
Alex Schwartz Analyst Color
Get additional color on Alex Schwartz's coverage of popular stocks
Alex Schwartz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Anaptysbio IncANAB | 4 | Strong Buy | $50.00 | +154.32% | Initiates Coverage On | 2 months ago |
Vtv Therapeutics IncVTVT | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Geron CorpGERN | 1 | Hold | $4.00 | N/A | Maintains | 6 years ago |
Puma Biotechnology IncPBYI | 1 | Strong Buy | $95.00 | N/A | Maintains | 6 years ago |
Clovis Oncology IncCLVSQ | 1 | Strong Buy | $110.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.